Bath & Body Works, Inc. $BBWI is Blueshift Asset Management LLC’s 3rd Largest Position

Blueshift Asset Management LLC grew its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 345.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 148,392 shares of the company’s stock after acquiring an additional 115,063 shares during the quarter. Bath & Body Works comprises 1.4% of Blueshift Asset Management LLC’s portfolio, making the stock its 3rd biggest position. Blueshift Asset Management LLC’s holdings in Bath & Body Works were worth $4,446,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Stonehage Fleming Financial Services Holdings Ltd purchased a new stake in shares of Bath & Body Works during the 2nd quarter worth about $33,000. SVB Wealth LLC acquired a new position in Bath & Body Works during the first quarter valued at approximately $35,000. Geneos Wealth Management Inc. grew its stake in Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares during the period. Parallel Advisors LLC increased its position in shares of Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after acquiring an additional 481 shares in the last quarter. Finally, Parkside Financial Bank & Trust raised its stake in shares of Bath & Body Works by 24.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after acquiring an additional 364 shares during the period. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Stock Up 9.1%

Shares of NYSE BBWI opened at $18.99 on Tuesday. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $41.87. The business has a 50 day moving average price of $23.55 and a two-hundred day moving average price of $27.45. The firm has a market cap of $3.89 billion, a PE ratio of 5.64, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the company earned $0.49 earnings per share. The business’s revenue for the quarter was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. On average, analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.2%. The ex-dividend date of this dividend is Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is currently 24.62%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on BBWI shares. Morgan Stanley reaffirmed an “equal weight” rating and set a $18.00 price target (down from $43.00) on shares of Bath & Body Works in a research report on Friday, November 21st. The Goldman Sachs Group cut Bath & Body Works from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $39.00 to $17.00 in a research note on Thursday, November 20th. Bank of America lowered their target price on Bath & Body Works from $40.00 to $32.00 and set a “buy” rating for the company in a research note on Thursday, November 20th. New Street Research set a $26.00 target price on Bath & Body Works in a report on Monday, November 24th. Finally, Telsey Advisory Group cut Bath & Body Works from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $38.00 to $17.00 in a report on Friday, November 21st. Six analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $25.17.

Insider Activity at Bath & Body Works

In related news, Director Stephen D. Steinour bought 6,700 shares of the business’s stock in a transaction dated Friday, November 21st. The shares were acquired at an average price of $14.86 per share, for a total transaction of $99,562.00. Following the purchase, the director owned 48,175 shares in the company, valued at $715,880.50. This trade represents a 16.15% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Steven E. Voskuil purchased 20,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average price of $15.04 per share, with a total value of $300,800.00. Following the completion of the purchase, the director directly owned 33,925 shares of the company’s stock, valued at approximately $510,232. This represents a 143.63% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased a total of 33,513 shares of company stock worth $500,442 over the last quarter. Company insiders own 0.26% of the company’s stock.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.